Endo International | ENDP - Ativo Circulante



Ativo Circulante Alterar Data
AbbVie USD 33.67B 140M 2026-06
Amarin USD 602.76M 23.26M 2026-06
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Coherus Biosciences USD 133.79M 72.25M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Phibro Animal Health USD 935.51M 41.44M 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Takeda JPY 3.15T 59.77B 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zoetis USD 6.36B 118M 2026-06